专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US09049025B1 Method of decrypting encrypted information for unsecure phone 有权
标题翻译：对不安全电话解密加密信息的方法
公开(公告)号：US09049025B1
公开(公告)日：2015-06-02
申请号：US13164138
申请日：2011-06-20
申请人： Ye Huang , Jerry Kupsh , Amir Mayblum
发明人： Ye Huang , Jerry Kupsh , Amir Mayblum
IPC分类号： H04L9/32 , H04L12/58
CPC分类号： H04L9/32 , H04L51/066 , H04W12/02
摘要： A server receives encrypted information for an intended recipient. The server determines, based on recipient information, whether the recipient's device is able to decrypt the encrypted information. If so, the encrypted information is provided to the device. Upon determining that the device is unable to decrypt the encrypted information, the server sends a notification message to the device. The notification message indicates that the encrypted message has been received. In response to the notification message, the server receives a response from the device. If the device is successfully authenticated, based on the response, the server decrypts the encrypted information and provides the decrypted information to the device for presentation to the recipient.
摘要翻译：服务器接收预期接收者的加密信息。服务器根据收件人信息确定收件人的设备是否能够解密加密的信息。如果是这样，则将加密的信息提供给设备。在确定设备无法解密加密信息后，服务器向设备发送通知消息。通知消息指示已经接收到加密的消息。响应于通知消息，服务器从设备接收响应。如果设备被成功认证，则基于该响应，服务器解密加密信息并将解密的信息提供给设备以呈现给接收者。

2. 发明授权

US08588818B2 Location-based broadcast messaging to mobile devices located in or entering into a defined geographic area 有权
标题翻译：基于位置的广播消息传送到位于或进入定义的地理区域的移动设备
公开(公告)号：US08588818B2
公开(公告)日：2013-11-19
申请号：US13291718
申请日：2011-11-08
申请人： Ye Huang , Jerry Kupsh , Hugh Fletcher , Amir Mayblum
发明人： Ye Huang , Jerry Kupsh , Hugh Fletcher , Amir Mayblum
IPC分类号： H04M11/04 , G08G1/123 , H04N7/025
CPC分类号： H04W4/06 , H04L69/22 , H04W4/02
摘要： For a location-based broadcast messaging service, a broadcast server receives a broadcast request from a business application server. The broadcast request includes a message, at least one identifier for target mobile devices, and an identifier for a location. The broadcast server sends a location query including the identifier for the location to location agents associated with the target mobile devices. In response to receiving the location query, each location agent determines whether the location of the associated mobile device is within or otherwise satisfies a requirement related to the identified location. If the location of the device is within the identified location or satisfies the requirement, the location agent sends a query response to the broadcast server and receives, from the broadcast server, the message included in the broadcast request. The broadcast request can include a time-period identifier, such that the location agent determines the device location during the time-period.
摘要翻译：对于基于位置的广播消息服务，广播服务器从业务应用服务器接收广播请求。广播请求包括消息，目标移动设备的至少一个标识符以及位置的标识符。广播服务器将包括该位置的标识符的位置查询发送到与目标移动设备相关联的位置代理。响应于接收到位置查询，每个位置代理确定相关联的移动设备的位置是否在其中，或者满足与所识别的位置相关的要求。如果设备的位置在识别的位置内或满足要求，则位置代理向广播服务器发送查询响应，并从广播服务器接收包含在广播请求中的消息。广播请求可以包括时间段标识符，使得位置代理在时间段期间确定设备位置。

3. 发明申请

US20130115872A1 LOCATION-BASED BROADCAST MESSAGING TO MOBILE DEVICES LOCATED IN OR ENTERING INTO A DEFINED GEOGRAPHIC AREA 有权
标题翻译：位于基于位置的广播消息传送到位于定义的地理区域的移动设备
公开(公告)号：US20130115872A1
公开(公告)日：2013-05-09
申请号：US13291718
申请日：2011-11-08
申请人： Ye Huang , Jerry Kupsh , Hugh Fletcher , Amir Mayblum
发明人： Ye Huang , Jerry Kupsh , Hugh Fletcher , Amir Mayblum
IPC分类号： H04W4/06
CPC分类号： H04W4/06 , H04L69/22 , H04W4/02
摘要： For a location-based broadcast messaging service, a broadcast server receives a broadcast request from a business application server. The broadcast request includes a message, at least one identifier for target mobile devices, and an identifier for a location. The broadcast server sends a location query including the identifier for the location to location agents associated with the target mobile devices. In response to receiving the location query, each location agent determines whether the location of the associated mobile device is within or otherwise satisfies a requirement related to the identified location. If the location of the device is within the identified location or satisfies the requirement, the location agent sends a query response to the broadcast server and receives, from the broadcast server, the message included in the broadcast request. The broadcast request can include a time-period identifier, such that the location agent determines the device location during the time-period.
摘要翻译：对于基于位置的广播消息服务，广播服务器从业务应用服务器接收广播请求。广播请求包括消息，目标移动设备的至少一个标识符以及位置的标识符。广播服务器将包括该位置的标识符的位置查询发送到与目标移动设备相关联的位置代理。响应于接收到位置查询，每个位置代理确定相关联的移动设备的位置是否在其中，或者满足与所识别的位置相关的要求。如果设备的位置在识别的位置内或满足要求，则位置代理向广播服务器发送查询响应，并从广播服务器接收包含在广播请求中的消息。广播请求可以包括时间段标识符，使得位置代理在时间段期间确定设备位置。

4. 发明授权

US08590057B1 Encryption and authentication of communications and content payload over existing networks 有权
标题翻译：现有网络上的通信和内容有效载荷的加密和认证
公开(公告)号：US08590057B1
公开(公告)日：2013-11-19
申请号：US13184119
申请日：2011-07-15
申请人： Amir Mayblum , Ye Huang
发明人： Amir Mayblum , Ye Huang
IPC分类号： H04L9/38 , H04L9/32
CPC分类号： H04L9/0891 , H04L63/0428 , H04L63/062 , H04L63/08
摘要： A server may receive encryption key requests that each identify a sender of the encryption key request and at least one recipient of information that is to be encrypted with the requested encryption key. In response, an encryption key may be sent to the sender of the encryption key request. Information identifying the sender and the at least one recipient may be stored. The server may receive decryption key requests that each identify a sender of the decryption key request and a sender of encrypted information. In response, a decryption key may be sent to the sender of the decryption key request if and only if the sender of encrypted information and the sender of the decryption key request, as both identified by the information in the decryption key request, match, respectively, a sender of an encryption key request and an associated recipient, as both identified by the stored information.
摘要翻译：服务器可以接收加密密钥请求，每个加密密钥请求每个标识加密密钥请求的发送者以及要使用所请求的加密密钥加密的信息的至少一个接收者。作为响应，加密密钥可以被发送到加密密钥请求的发送者。可以存储识别发送者和至少一个接收者的信息。服务器可以接收解密密钥请求，每个解密密钥请求标识解密密钥请求的发送者和加密信息的发送者。作为响应，当且仅当加密信息的发送者和解密密钥请求的发送者两者分别由解密密钥请求中的信息识别的请求匹配时，解密密钥可以被发送到解密密钥请求的发送者，加密密钥请求的发送者和相关联的接收者，两者都由所存储的信息标识。

5. 发明申请

US20120165358A1 CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS 审中-公开
标题翻译：阿片类和非诺贝特药物的控制释放配方
公开(公告)号：US20120165358A1
公开(公告)日：2012-06-28
申请号：US13300380
申请日：2011-11-18
申请人： Evangeline Cruz , Atul D. Ayer , Brenda J. Pollock , Carmelita Garcia , Sherry Li , Alfredo M. Wong , Lawrence G. Hamel , Cheri Enders Klein , Yihong Qiu , Ye Huang
发明人： Evangeline Cruz , Atul D. Ayer , Brenda J. Pollock , Carmelita Garcia , Sherry Li , Alfredo M. Wong , Lawrence G. Hamel , Cheri Enders Klein , Yihong Qiu , Ye Huang
IPC分类号： A61K31/485 , A61P25/04 , A61P29/00
CPC分类号： A61K9/2086 , A61K9/0004 , A61K9/209 , A61K9/4808 , A61K9/5084 , A61K31/00 , A61K31/16 , A61K31/165 , A61K31/167 , A61K31/485 , A61K45/06 , A61K2300/00
摘要： Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.
摘要翻译：提供了持续释放剂型，每天两次口服给予患者以缓解疼痛。持续释放剂型包括速释组分和持续释放组分，其中速释组分和持续释放组分共同含有治疗有效量的阿片样镇痛剂和治疗有效量的非阿片类止痛剂。在优选的实施方案中，非阿片类镇痛剂是对乙酰氨基酚，阿片类镇痛剂是氢可酮及其药学上可接受的盐，并且在优选的实施方案中，药学上可接受的盐是酒石酸氢盐。剂型在患者中产生血浆曲线，其特征在于氢可酮的C max为约0.6ng / mL / mg至约1.4ng / mL / mg，氢可酮的AUC为约9.1ng * hr / mL / mg至约 19.9ng * hr / mL / mg（每毫克给予的氢可酮酮可乐酮），对乙酰氨基酚的C max为约2.8ng / mL / mg至7.9ng / mL / mg，对乙酰氨基酚的AUC为约28.6ng * hr / mL / mg和约59.1ng * hr / mL / mg（施用每mg对乙酰氨基酚）。

6. 发明授权

US10490966B1 Optical fiber device 有权
公开(公告)号：US10490966B1
公开(公告)日：2019-11-26
申请号：US15851319
申请日：2017-12-21
申请人： Ye Huang , Gregory D. Goodno , Joshua E. Rothenberg
发明人： Ye Huang , Gregory D. Goodno , Joshua E. Rothenberg
IPC分类号： H01S3/067 , H01S3/091 , H01S3/16
CPC分类号： H01S3/06708 , H01S3/091 , H01S3/1608 , H01S3/1616 , H01S3/1618
摘要： One example includes an optical fiber device. The device includes an optical fiber core that extends axially along a length of the optical fiber device and an optical fiber cladding that surrounds the optical fiber core and extends axially along a length of the optical fiber device. The device also includes a polymer inner jacket that surrounds the optical fiber cladding and extends axially along a length of the optical fiber device. The device further includes a thermally-conductive outer jacket that surrounds the polymer inner jacket and extends axially along a length of the optical fiber device.

7. 发明申请

US20050158382A1 Controlled release formulations of opioid and nonopioid analgesics 审中-公开
标题翻译：阿片样物质和非阿片类止痛剂的控制释放制剂
公开(公告)号：US20050158382A1
公开(公告)日：2005-07-21
申请号：US10949141
申请日：2004-09-24
申请人： Evangeline Cruz , Atul Ayer , Brenda Pollock , Carmelita Garcia , Sherry Li , Alfredo Wong , Lawrence Hamel , Cheri Klein , Yihong Qiu , Ye Huang
发明人： Evangeline Cruz , Atul Ayer , Brenda Pollock , Carmelita Garcia , Sherry Li , Alfredo Wong , Lawrence Hamel , Cheri Klein , Yihong Qiu , Ye Huang
IPC分类号： A61K9/00 , A61K9/20 , A61K9/24 , A61K9/48 , A61K9/50 , A61K9/52 , A61K31/00 , A61K31/16 , A61K31/165 , A61K31/485 , A61K45/06 , A61K9/22
CPC分类号： A61K9/2086 , A61K9/0004 , A61K9/209 , A61K9/4808 , A61K9/5084 , A61K31/00 , A61K31/16 , A61K31/165 , A61K31/167 , A61K31/485 , A61K45/06 , A61K2300/00
摘要： Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.
摘要翻译：提供了持续释放剂型，每天两次口服给予患者以缓解疼痛。持续释放剂型包括速释组分和持续释放组分，其中速释组分和持续释放组分共同含有治疗有效量的阿片样镇痛剂和治疗有效量的非阿片类止痛剂。在优选的实施方案中，非阿片类镇痛剂是对乙酰氨基酚，阿片类镇痛剂是氢可酮及其药学上可接受的盐，并且在优选的实施方案中，药学上可接受的盐是酒石酸氢盐。剂型在患者中产生血浆曲线，其特征在于氢可酮的C max为约0.6ng / mL / mg至约1.4ng / mL / mg，氢可酮的AUC为约9.1ng * hr / mL / mg至约 19.9ng * hr / mL / mg（每毫克给予的氢可酮酮可乐酮），对乙酰氨基酚的C max为约2.8ng / mL / mg至7.9ng / mL / mg，对乙酰氨基酚的AUC为约28.6ng * hr / mL / mg和约59.1ng * hr / mL / mg（施用每mg对乙酰氨基酚）。

8. 发明授权

US06714217B2 System and method for providing a graphical user interface to, for building, and/or for monitoring a telecommunication network 失效
标题翻译：用于提供用于构建和/或监视电信网络的图形用户界面的系统和方法
公开(公告)号：US06714217B2
公开(公告)日：2004-03-30
申请号：US09216354
申请日：1998-12-18
申请人： Ye Huang , William Lawton Crowe , Royal Dean Howell
发明人： Ye Huang , William Lawton Crowe , Royal Dean Howell
IPC分类号： G06F314
CPC分类号： H04L41/22 , H04Q3/0083 , H04Q3/0087 , H04Q2213/13175
摘要： A system and method for providing a graphical user interface (GUI) for network development, management, and monitoring includes a GUI front end that provides a graphical representation of a telecommunication network comprised of communication devices represented by GUI network elements. A network proxy provides a communication layer between the GUI and a network server and allows the GUI to connect to multiple instances of a network server without having to hard code the connections to the network servers. The network proxy transmits commands and messages between the network server and the GUI. The network server determines how to handle traffic in the network model, such as how to provide call setup, call routing, and call tear down. The network server transmits call routing commands and messages to the network proxy which dispatches them to the GUI. An external systems interface provides the mechanism for which the network server communicates with communication devices in an external system.
摘要翻译：用于提供用于网络开发，管理和监视的图形用户界面（GUI）的系统和方法包括GUI前端，其提供由GUI网络元件表示的通信设备组成的电信网络的图形表示。网络代理在GUI和网络服务器之间提供通信层，并允许GUI连接到网络服务器的多个实例，而不必对与网络服务器的连接进行硬编码。网络代理在网络服务器和GUI之间传输命令和消息。网络服务器确定如何处理网络模型中的流量，例如如何提供呼叫建立，呼叫路由和呼叫拆除。网络服务器将呼叫路由命令和消息发送到网络代理，将其发送到GUI。外部系统接口提供了网络服务器与外部系统中的通信设备进行通信的机制。

9. 发明申请

US20060251721A1 Controlled release formulations of opioid and nonopioid analgesics 审中-公开
标题翻译：阿片样物质和非阿片类止痛剂的控制释放制剂
公开(公告)号：US20060251721A1
公开(公告)日：2006-11-09
申请号：US11480124
申请日：2006-06-30
申请人： Evangeline Cruz , Atul Ayer , Brenda Pollock , Carmelita Garcia , Sherry Li , Alfredo Wong , Lawrence Hamel , Cheri Klein , Yihong Qiu , Ye Huang
发明人： Evangeline Cruz , Atul Ayer , Brenda Pollock , Carmelita Garcia , Sherry Li , Alfredo Wong , Lawrence Hamel , Cheri Klein , Yihong Qiu , Ye Huang
IPC分类号： A61K31/485 , A61K9/22 , A61K31/16
CPC分类号： A61K9/2086 , A61K9/0004 , A61K9/209 , A61K9/4808 , A61K9/5084 , A61K31/00 , A61K31/16 , A61K31/165 , A61K31/167 , A61K31/485 , A61K45/06 , A61K2300/00
摘要： Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.
摘要翻译：提供了持续释放剂型，每天两次口服给予患者以缓解疼痛。持续释放剂型包括速释组分和持续释放组分，其中速释组分和持续释放组分共同含有治疗有效量的阿片样镇痛剂和治疗有效量的非阿片类止痛剂。在优选的实施方案中，非阿片类镇痛剂是对乙酰氨基酚，阿片类镇痛剂是氢可酮及其药学上可接受的盐，并且在优选的实施方案中，药学上可接受的盐是酒石酸氢盐。剂型在患者中产生血浆曲线，其特征在于氢可酮的C max为约0.6ng / mL / mg至约1.4ng / mL / mg，氢可酮的AUC为约9.1ng * hr / mL / mg至约 19.9ng * hr / mL / mg（每毫克给予的氢可酮酮可乐酮），对乙酰氨基酚的C max为约2.8ng / mL / mg至7.9ng / mL / mg，对乙酰氨基酚的AUC为约28.6ng * hr / mL / mg和约59.1ng * hr / mL / mg（施用每mg对乙酰氨基酚）。

10. 发明申请

US20120251590A1 CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS 审中-公开
标题翻译：阿片类和非诺贝特药物的控制释放配方
公开(公告)号：US20120251590A1
公开(公告)日：2012-10-04
申请号：US13436727
申请日：2012-03-30
申请人： Evangeline Cruz , Atul D. Ayer , Brenda J. Pollock , Carmelita Garcia , Sherry Li , Alfredo M. Wong , Lawrence G. Hamel , Cheri Enders Klein , Yihong Qiu , Ye Huang
发明人： Evangeline Cruz , Atul D. Ayer , Brenda J. Pollock , Carmelita Garcia , Sherry Li , Alfredo M. Wong , Lawrence G. Hamel , Cheri Enders Klein , Yihong Qiu , Ye Huang
IPC分类号： A61K9/00 , A61P25/04 , A61P29/00 , A61K31/485
CPC分类号： A61K9/2086 , A61K9/0004 , A61K9/209 , A61K9/4808 , A61K9/5084 , A61K31/00 , A61K31/16 , A61K31/165 , A61K31/167 , A61K31/485 , A61K45/06 , A61K2300/00
摘要： Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic.
摘要翻译：提供了持续释放剂型，每天两次口服给予患者以缓解疼痛。持续释放剂型包括速释组分和持续释放组分，其中速释组分和持续释放组分共同含有治疗有效量的阿片样镇痛剂和治疗有效量的非阿片类止痛剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式